BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31228214)

  • 1. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.
    Lang S; Duan Y; Liu J; Torralba MG; Kuelbs C; Ventura-Cots M; Abraldes JG; Bosques-Padilla F; Verna EC; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Lucey MR; Louvet A; Mathurin P; Garcia-Tsao G; Ho SB; Tu XM; Bataller R; Stärkel P; Fouts DE; Schnabl B
    Hepatology; 2020 Feb; 71(2):522-538. PubMed ID: 31228214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fecal mycobiome in non-alcoholic fatty liver disease.
    Demir M; Lang S; Hartmann P; Duan Y; Martin A; Miyamoto Y; Bondareva M; Zhang X; Wang Y; Kasper P; Bang C; Roderburg C; Tacke F; Steffen HM; Goeser T; Kruglov A; Eckmann L; Stärkel P; Fouts DE; Schnabl B
    J Hepatol; 2022 Apr; 76(4):788-799. PubMed ID: 34896404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of Opportunistic Enteric Fungal Pathogens and Occurrence of Gut Inflammation in Human Liver Echinococcosis.
    Wang Y; Guo A; Liu Z; Zou Y; Zhu W; Wu S; Zhang S; Guo X; Zhang S; Pu L; Zhu XQ; Zhu G; Cai X; Wang S
    Microbiol Spectr; 2022 Oct; 10(5):e0145322. PubMed ID: 36098525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal fungi contribute to development of alcoholic liver disease.
    Yang AM; Inamine T; Hochrath K; Chen P; Wang L; Llorente C; Bluemel S; Hartmann P; Xu J; Koyama Y; Kisseleva T; Torralba MG; Moncera K; Beeri K; Chen CS; Freese K; Hellerbrand C; Lee SM; Hoffman HM; Mehal WZ; Garcia-Tsao G; Mutlu EA; Keshavarzian A; Brown GD; Ho SB; Bataller R; Stärkel P; Fouts DE; Schnabl B
    J Clin Invest; 2017 Jun; 127(7):2829-2841. PubMed ID: 28530644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host Factors Associated with Gut Mycobiome Structure.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
    mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.
    Chu H; Duan Y; Lang S; Jiang L; Wang Y; Llorente C; Liu J; Mogavero S; Bosques-Padilla F; Abraldes JG; Vargas V; Tu XM; Yang L; Hou X; Hube B; Stärkel P; Schnabl B
    J Hepatol; 2020 Mar; 72(3):391-400. PubMed ID: 31606552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
    Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
    J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungi-Bacteria Correlation in Alcoholic Hepatitis Patients.
    Gao B; Zhang X; Schnabl B
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33672887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicken Intestinal Mycobiome: Initial Characterization and Its Response to Bacitracin Methylene Disalicylate.
    Robinson K; Xiao Y; Johnson TJ; Chen B; Yang Q; Lyu W; Wang J; Fansler N; Becker S; Liu J; Yang H; Zhang G
    Appl Environ Microbiol; 2020 Jun; 86(13):. PubMed ID: 32358003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogeography, succession, and origin of the chicken intestinal mycobiome.
    Robinson K; Yang Q; Stewart S; Whitmore MA; Zhang G
    Microbiome; 2022 Apr; 10(1):55. PubMed ID: 35365230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for the mycobiome in liver disease.
    Zeng S; Schnabl B
    Liver Int; 2022 Apr; 42(4):729-741. PubMed ID: 34995410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Study Provides the First Direct Evidence That Interindividual Variations in Fecal β-Lactamase Activity Affect the Gut Mycobiota Dynamics in Response to β-Lactam Antibiotics.
    Delavy M; Burdet C; Sertour N; Devente S; Docquier JD; Grall N; Volant S; Ghozlane A; Duval X; Mentré F; d'Enfert C; Bougnoux ME;
    mBio; 2022 Dec; 13(6):e0288022. PubMed ID: 36448778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.
    Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Pietrzak B; Schmidt M; Galus Ł; Mackiewicz J; Mackiewicz A; Kozlowski P; Philips A
    Cancer Immunol Res; 2024 Apr; 12(4):427-439. PubMed ID: 38315788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic anti-commensal response to fungi analyzed by flow cytometry is related to gut mycobiome ecology.
    Moreno-Sabater A; Autaa G; Sterlin D; Jerbi A; Villette R; Holm JB; Parizot C; Selim S; Senghor Y; Ghillani-Dalbin P; Bachmeyer C; Hennequin C; Gorochov G; Larsen M
    Microbiome; 2020 Nov; 8(1):159. PubMed ID: 33190643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.
    Zhang L; Chen C; Chai D; Li C; Qiu Z; Kuang T; Liu L; Deng W; Wang W
    J Transl Med; 2023 Feb; 21(1):126. PubMed ID: 36793057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
    Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
    J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.